nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—CYP2A6—Pilocarpine—glaucoma	0.246	0.338	CbGbCtD
Metyrapone—CYP2E1—Pilocarpine—glaucoma	0.163	0.223	CbGbCtD
Metyrapone—CYP2E1—Methazolamide—glaucoma	0.11	0.151	CbGbCtD
Metyrapone—CYP3A4—Pilocarpine—glaucoma	0.0492	0.0677	CbGbCtD
Metyrapone—CYP3A4—Brinzolamide—glaucoma	0.0386	0.0531	CbGbCtD
Metyrapone—CYP3A4—Dorzolamide—glaucoma	0.0373	0.0513	CbGbCtD
Metyrapone—CYP3A4—Methazolamide—glaucoma	0.0333	0.0457	CbGbCtD
Metyrapone—CYP3A4—Acetazolamide—glaucoma	0.0266	0.0365	CbGbCtD
Metyrapone—CYP3A4—Clonidine—glaucoma	0.024	0.033	CbGbCtD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—MAS1—glaucoma	0.0083	0.133	CbGpPWpGaD
Metyrapone—Bone marrow depression—Methazolamide—glaucoma	0.00716	0.0341	CcSEcCtD
Metyrapone—Dermatitis atopic—Latanoprost—glaucoma	0.00632	0.0301	CcSEcCtD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—ACE2—glaucoma	0.00629	0.101	CbGpPWpGaD
Metyrapone—Hirsutism—Bimatoprost—glaucoma	0.00624	0.0297	CcSEcCtD
Metyrapone—ABCC3—ABC-family proteins mediated transport—PEX19—glaucoma	0.00418	0.0673	CbGpPWpGaD
Metyrapone—Dermatitis atopic—Travoprost—glaucoma	0.00412	0.0196	CcSEcCtD
Metyrapone—Hypertension—Dipivefrin—glaucoma	0.00387	0.0184	CcSEcCtD
Metyrapone—Pain—Dipivefrin—glaucoma	0.00313	0.0149	CcSEcCtD
Metyrapone—Abdominal discomfort—Carbachol—glaucoma	0.00308	0.0147	CcSEcCtD
Metyrapone—Pancytopenia—Methazolamide—glaucoma	0.00288	0.0137	CcSEcCtD
Metyrapone—Endocrine disorder—Clonidine—glaucoma	0.00279	0.0133	CcSEcCtD
Metyrapone—Vomiting—Physostigmine—glaucoma	0.00273	0.013	CcSEcCtD
Metyrapone—Pain—Echothiophate—glaucoma	0.00262	0.0125	CcSEcCtD
Metyrapone—Nausea—Physostigmine—glaucoma	0.00255	0.0122	CcSEcCtD
Metyrapone—Abdominal discomfort—Apraclonidine—glaucoma	0.00225	0.0107	CcSEcCtD
Metyrapone—Alopecia—Levobunolol—glaucoma	0.00224	0.0107	CcSEcCtD
Metyrapone—CYP11B2—Endogenous sterols—CYP1B1—glaucoma	0.00221	0.0355	CbGpPWpGaD
Metyrapone—Hypertension—Metipranolol—glaucoma	0.00217	0.0103	CcSEcCtD
Metyrapone—CYP11B1—Endogenous sterols—CYP1B1—glaucoma	0.0019	0.0306	CbGpPWpGaD
Metyrapone—Abdominal discomfort—Brinzolamide—glaucoma	0.00181	0.00863	CcSEcCtD
Metyrapone—Hypotension—Carteolol—glaucoma	0.00178	0.00847	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00173	0.00823	CcSEcCtD
Metyrapone—Hypotension—Carbachol—glaucoma	0.00171	0.00813	CcSEcCtD
Metyrapone—Angiopathy—Apraclonidine—glaucoma	0.0017	0.00811	CcSEcCtD
Metyrapone—Hypotension—Levobunolol—glaucoma	0.00168	0.008	CcSEcCtD
Metyrapone—Angiopathy—Bimatoprost—glaucoma	0.00165	0.00786	CcSEcCtD
Metyrapone—Nervous system disorder—Latanoprost—glaucoma	0.00164	0.00779	CcSEcCtD
Metyrapone—Skin disorder—Latanoprost—glaucoma	0.00162	0.00771	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00162	0.00769	CcSEcCtD
Metyrapone—Pain—Carbachol—glaucoma	0.00156	0.00744	CcSEcCtD
Metyrapone—Pain—Levobunolol—glaucoma	0.00154	0.00732	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Methazolamide—glaucoma	0.00149	0.00708	CcSEcCtD
Metyrapone—Angiopathy—Brimonidine—glaucoma	0.00146	0.00696	CcSEcCtD
Metyrapone—Abdominal pain—Carbachol—glaucoma	0.00144	0.00687	CcSEcCtD
Metyrapone—Pain—Latanoprost—glaucoma	0.00143	0.00679	CcSEcCtD
Metyrapone—Angiopathy—Travoprost—glaucoma	0.00139	0.00662	CcSEcCtD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—NOS3—glaucoma	0.00138	0.0223	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00138	0.00658	CcSEcCtD
Metyrapone—Angiopathy—Brinzolamide—glaucoma	0.00137	0.00653	CcSEcCtD
Metyrapone—Hypertension—Bimatoprost—glaucoma	0.00137	0.00651	CcSEcCtD
Metyrapone—Alopecia—Dorzolamide—glaucoma	0.00136	0.00647	CcSEcCtD
Metyrapone—Dizziness—Metipranolol—glaucoma	0.00136	0.00647	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00134	0.00638	CcSEcCtD
Metyrapone—Alopecia—Brinzolamide—glaucoma	0.00134	0.00636	CcSEcCtD
Metyrapone—Nervous system disorder—Apraclonidine—glaucoma	0.00131	0.00623	CcSEcCtD
Metyrapone—Skin disorder—Apraclonidine—glaucoma	0.0013	0.00617	CcSEcCtD
Metyrapone—Headache—Metipranolol—glaucoma	0.00129	0.00613	CcSEcCtD
Metyrapone—Alopecia—Pilocarpine—glaucoma	0.00129	0.00612	CcSEcCtD
Metyrapone—Nervous system disorder—Bimatoprost—glaucoma	0.00127	0.00604	CcSEcCtD
Metyrapone—Dizziness—Carteolol—glaucoma	0.00126	0.00599	CcSEcCtD
Metyrapone—Skin disorder—Bimatoprost—glaucoma	0.00126	0.00598	CcSEcCtD
Metyrapone—Dizziness—Diclofenamide—glaucoma	0.00124	0.00589	CcSEcCtD
Metyrapone—Nausea—Metipranolol—glaucoma	0.00122	0.00581	CcSEcCtD
Metyrapone—Hypertension—Brimonidine—glaucoma	0.00121	0.00577	CcSEcCtD
Metyrapone—Dizziness—Carbachol—glaucoma	0.00121	0.00575	CcSEcCtD
Metyrapone—Headache—Carteolol—glaucoma	0.00119	0.00568	CcSEcCtD
Metyrapone—Vomiting—Diclofenamide—glaucoma	0.00119	0.00566	CcSEcCtD
Metyrapone—Dizziness—Levobunolol—glaucoma	0.00119	0.00566	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00119	0.00565	CcSEcCtD
Metyrapone—Headache—Diclofenamide—glaucoma	0.00117	0.00558	CcSEcCtD
Metyrapone—Vomiting—Carbachol—glaucoma	0.00116	0.00553	CcSEcCtD
Metyrapone—Hypertension—Dorzolamide—glaucoma	0.00116	0.00551	CcSEcCtD
Metyrapone—Hypertension—Travoprost—glaucoma	0.00115	0.00548	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00115	0.00548	CcSEcCtD
Metyrapone—Headache—Carbachol—glaucoma	0.00114	0.00545	CcSEcCtD
Metyrapone—Pain—Apraclonidine—glaucoma	0.00114	0.00543	CcSEcCtD
Metyrapone—Hypertension—Brinzolamide—glaucoma	0.00114	0.00541	CcSEcCtD
Metyrapone—Nausea—Carteolol—glaucoma	0.00113	0.00538	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00113	0.00537	CcSEcCtD
Metyrapone—Headache—Levobunolol—glaucoma	0.00113	0.00536	CcSEcCtD
Metyrapone—Nervous system disorder—Brimonidine—glaucoma	0.00112	0.00534	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00112	0.00531	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00111	0.0053	CcSEcCtD
Metyrapone—Skin disorder—Brimonidine—glaucoma	0.00111	0.00529	CcSEcCtD
Metyrapone—Nausea—Diclofenamide—glaucoma	0.00111	0.00529	CcSEcCtD
Metyrapone—Pain—Bimatoprost—glaucoma	0.00111	0.00526	CcSEcCtD
Metyrapone—Dizziness—Latanoprost—glaucoma	0.0011	0.00525	CcSEcCtD
Metyrapone—Vomiting—Methazolamide—glaucoma	0.0011	0.00522	CcSEcCtD
Metyrapone—Hypertension—Pilocarpine—glaucoma	0.00109	0.0052	CcSEcCtD
Metyrapone—Gastrointestinal pain—Apraclonidine—glaucoma	0.00109	0.00519	CcSEcCtD
Metyrapone—Nausea—Carbachol—glaucoma	0.00109	0.00517	CcSEcCtD
Metyrapone—Headache—Methazolamide—glaucoma	0.00108	0.00514	CcSEcCtD
Metyrapone—Hypotension—Brimonidine—glaucoma	0.00107	0.00509	CcSEcCtD
Metyrapone—Nausea—Levobunolol—glaucoma	0.00107	0.00509	CcSEcCtD
Metyrapone—Nervous system disorder—Travoprost—glaucoma	0.00107	0.00508	CcSEcCtD
Metyrapone—Skin disorder—Travoprost—glaucoma	0.00106	0.00503	CcSEcCtD
Metyrapone—Abdominal pain—Apraclonidine—glaucoma	0.00105	0.00502	CcSEcCtD
Metyrapone—Nervous system disorder—Brinzolamide—glaucoma	0.00105	0.00502	CcSEcCtD
Metyrapone—Angiopathy—Clonidine—glaucoma	0.00105	0.00502	CcSEcCtD
Metyrapone—Headache—Latanoprost—glaucoma	0.00105	0.00497	CcSEcCtD
Metyrapone—Skin disorder—Brinzolamide—glaucoma	0.00104	0.00497	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00103	0.0049	CcSEcCtD
Metyrapone—Alopecia—Clonidine—glaucoma	0.00103	0.00489	CcSEcCtD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00102	0.0165	CbGpPWpGaD
Metyrapone—Nausea—Methazolamide—glaucoma	0.00102	0.00487	CcSEcCtD
Metyrapone—Hypotension—Dorzolamide—glaucoma	0.00102	0.00486	CcSEcCtD
Metyrapone—Hypotension—Travoprost—glaucoma	0.00102	0.00484	CcSEcCtD
Metyrapone—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—glaucoma	0.00101	0.0163	CbGpPWpGaD
Metyrapone—CYP11B2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00101	0.0163	CbGpPWpGaD
Metyrapone—Hypotension—Brinzolamide—glaucoma	0.001	0.00478	CcSEcCtD
Metyrapone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.001	0.0161	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000989	0.00471	CcSEcCtD
Metyrapone—Pain—Brimonidine—glaucoma	0.000979	0.00466	CcSEcCtD
Metyrapone—Hypotension—Pilocarpine—glaucoma	0.000966	0.0046	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Travoprost—glaucoma	0.00094	0.00447	CcSEcCtD
Metyrapone—Pain—Dorzolamide—glaucoma	0.000935	0.00445	CcSEcCtD
Metyrapone—Pain—Travoprost—glaucoma	0.000931	0.00443	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000928	0.00442	CcSEcCtD
Metyrapone—CYP2A6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000922	0.0148	CbGpPWpGaD
Metyrapone—Pain—Brinzolamide—glaucoma	0.000919	0.00438	CcSEcCtD
Metyrapone—Angiopathy—Betaxolol—glaucoma	0.000918	0.00437	CcSEcCtD
Metyrapone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000894	0.00426	CcSEcCtD
Metyrapone—Alopecia—Betaxolol—glaucoma	0.000894	0.00425	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000892	0.00425	CcSEcCtD
Metyrapone—Gastrointestinal pain—Travoprost—glaucoma	0.00089	0.00424	CcSEcCtD
Metyrapone—Pain—Pilocarpine—glaucoma	0.000884	0.00421	CcSEcCtD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000883	0.0142	CbGpPWpGaD
Metyrapone—Dizziness—Apraclonidine—glaucoma	0.000882	0.0042	CcSEcCtD
Metyrapone—CYP11B1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000871	0.014	CbGpPWpGaD
Metyrapone—Abdominal pain—Dorzolamide—glaucoma	0.000865	0.00411	CcSEcCtD
Metyrapone—Abdominal pain—Travoprost—glaucoma	0.000861	0.0041	CcSEcCtD
Metyrapone—Dizziness—Bimatoprost—glaucoma	0.000855	0.00407	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000855	0.00407	CcSEcCtD
Metyrapone—Vomiting—Apraclonidine—glaucoma	0.000848	0.00404	CcSEcCtD
Metyrapone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000845	0.00402	CcSEcCtD
Metyrapone—Headache—Apraclonidine—glaucoma	0.000836	0.00398	CcSEcCtD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00083	0.0134	CbGpPWpGaD
Metyrapone—Abdominal pain—Pilocarpine—glaucoma	0.000817	0.00389	CcSEcCtD
Metyrapone—Headache—Bimatoprost—glaucoma	0.00081	0.00386	CcSEcCtD
Metyrapone—Nervous system disorder—Clonidine—glaucoma	0.000809	0.00385	CcSEcCtD
Metyrapone—Skin disorder—Clonidine—glaucoma	0.000802	0.00382	CcSEcCtD
Metyrapone—Nausea—Apraclonidine—glaucoma	0.000792	0.00377	CcSEcCtD
Metyrapone—Dizziness—Acetazolamide—glaucoma	0.000789	0.00376	CcSEcCtD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000779	0.0125	CbGpPWpGaD
Metyrapone—Hypotension—Clonidine—glaucoma	0.000771	0.00367	CcSEcCtD
Metyrapone—Nausea—Bimatoprost—glaucoma	0.000768	0.00366	CcSEcCtD
Metyrapone—Vomiting—Acetazolamide—glaucoma	0.000759	0.00361	CcSEcCtD
Metyrapone—Dizziness—Brimonidine—glaucoma	0.000757	0.0036	CcSEcCtD
Metyrapone—Angiopathy—Timolol—glaucoma	0.00075	0.00357	CcSEcCtD
Metyrapone—Headache—Acetazolamide—glaucoma	0.000748	0.00356	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000744	0.00354	CcSEcCtD
Metyrapone—Alopecia—Timolol—glaucoma	0.00073	0.00347	CcSEcCtD
Metyrapone—CYP2E1—Tamoxifen metabolism—CYP1B1—glaucoma	0.000729	0.0117	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000724	0.0117	CbGpPWpGaD
Metyrapone—Dizziness—Dorzolamide—glaucoma	0.000723	0.00344	CcSEcCtD
Metyrapone—Dizziness—Travoprost—glaucoma	0.00072	0.00343	CcSEcCtD
Metyrapone—Headache—Brimonidine—glaucoma	0.000717	0.00341	CcSEcCtD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000715	0.0115	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Clonidine—glaucoma	0.000713	0.00339	CcSEcCtD
Metyrapone—Dizziness—Brinzolamide—glaucoma	0.000711	0.00338	CcSEcCtD
Metyrapone—Nausea—Acetazolamide—glaucoma	0.000709	0.00337	CcSEcCtD
Metyrapone—Pain—Clonidine—glaucoma	0.000706	0.00336	CcSEcCtD
Metyrapone—Nervous system disorder—Betaxolol—glaucoma	0.000705	0.00335	CcSEcCtD
Metyrapone—Skin disorder—Betaxolol—glaucoma	0.000698	0.00332	CcSEcCtD
Metyrapone—Vomiting—Dorzolamide—glaucoma	0.000695	0.00331	CcSEcCtD
Metyrapone—Headache—Dorzolamide—glaucoma	0.000685	0.00326	CcSEcCtD
Metyrapone—Vomiting—Brinzolamide—glaucoma	0.000684	0.00325	CcSEcCtD
Metyrapone—Dizziness—Pilocarpine—glaucoma	0.000683	0.00325	CcSEcCtD
Metyrapone—Headache—Travoprost—glaucoma	0.000682	0.00325	CcSEcCtD
Metyrapone—Nausea—Brimonidine—glaucoma	0.00068	0.00324	CcSEcCtD
Metyrapone—Gastrointestinal pain—Clonidine—glaucoma	0.000675	0.00321	CcSEcCtD
Metyrapone—Headache—Brinzolamide—glaucoma	0.000674	0.00321	CcSEcCtD
Metyrapone—Hypotension—Betaxolol—glaucoma	0.000671	0.0032	CcSEcCtD
Metyrapone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000666	0.0107	CbGpPWpGaD
Metyrapone—Vomiting—Pilocarpine—glaucoma	0.000657	0.00313	CcSEcCtD
Metyrapone—Abdominal pain—Clonidine—glaucoma	0.000652	0.0031	CcSEcCtD
Metyrapone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000651	0.0105	CbGpPWpGaD
Metyrapone—Nausea—Dorzolamide—glaucoma	0.00065	0.00309	CcSEcCtD
Metyrapone—Headache—Pilocarpine—glaucoma	0.000647	0.00308	CcSEcCtD
Metyrapone—Nausea—Travoprost—glaucoma	0.000647	0.00308	CcSEcCtD
Metyrapone—Nausea—Brinzolamide—glaucoma	0.000639	0.00304	CcSEcCtD
Metyrapone—Hypertension—Timolol—glaucoma	0.000621	0.00296	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Betaxolol—glaucoma	0.00062	0.00295	CcSEcCtD
Metyrapone—ABCC3—NRF2 pathway—SLC6A13—glaucoma	0.000615	0.00989	CbGpPWpGaD
Metyrapone—Pain—Betaxolol—glaucoma	0.000614	0.00292	CcSEcCtD
Metyrapone—Nausea—Pilocarpine—glaucoma	0.000614	0.00292	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000608	0.00289	CcSEcCtD
Metyrapone—Nervous system disorder—Timolol—glaucoma	0.000576	0.00274	CcSEcCtD
Metyrapone—Skin disorder—Timolol—glaucoma	0.00057	0.00271	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—GSTT1—glaucoma	0.000554	0.0089	CbGpPWpGaD
Metyrapone—Hypotension—Timolol—glaucoma	0.000548	0.00261	CcSEcCtD
Metyrapone—Dizziness—Clonidine—glaucoma	0.000546	0.0026	CcSEcCtD
Metyrapone—Vomiting—Clonidine—glaucoma	0.000525	0.0025	CcSEcCtD
Metyrapone—Headache—Clonidine—glaucoma	0.000517	0.00246	CcSEcCtD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	0.000517	0.00831	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Timolol—glaucoma	0.000507	0.00241	CcSEcCtD
Metyrapone—ABCC3—NRF2 pathway—TXN—glaucoma	0.000505	0.00812	CbGpPWpGaD
Metyrapone—Pain—Timolol—glaucoma	0.000502	0.00239	CcSEcCtD
Metyrapone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000496	0.00797	CbGpPWpGaD
Metyrapone—Nausea—Clonidine—glaucoma	0.00049	0.00233	CcSEcCtD
Metyrapone—Gastrointestinal pain—Timolol—glaucoma	0.00048	0.00228	CcSEcCtD
Metyrapone—CYP11B1—Biological oxidations—GSTT1—glaucoma	0.000477	0.00767	CbGpPWpGaD
Metyrapone—Dizziness—Betaxolol—glaucoma	0.000475	0.00226	CcSEcCtD
Metyrapone—Abdominal pain—Timolol—glaucoma	0.000464	0.00221	CcSEcCtD
Metyrapone—Vomiting—Betaxolol—glaucoma	0.000457	0.00217	CcSEcCtD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000454	0.0073	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—SLC6A1—glaucoma	0.00045	0.00724	CbGpPWpGaD
Metyrapone—Headache—Betaxolol—glaucoma	0.00045	0.00214	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—CYP1B1—glaucoma	0.000441	0.00709	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000437	0.00703	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP1B1—glaucoma	0.000435	0.007	CbGpPWpGaD
Metyrapone—Nausea—Betaxolol—glaucoma	0.000427	0.00203	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000412	0.00663	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000407	0.00654	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000398	0.0064	CbGpPWpGaD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000393	0.00632	CbGpPWpGaD
Metyrapone—CYP2E1—Tryptophan metabolism—CYP1B1—glaucoma	0.000389	0.00626	CbGpPWpGaD
Metyrapone—Dizziness—Timolol—glaucoma	0.000388	0.00185	CcSEcCtD
Metyrapone—CYP11B2—Metabolism—NARFL—glaucoma	0.000388	0.00624	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CA5A—glaucoma	0.000388	0.00624	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	0.000385	0.0062	CbGpPWpGaD
Metyrapone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000382	0.00615	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—CYP1B1—glaucoma	0.00038	0.00611	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP1B1—glaucoma	0.000375	0.00603	CbGpPWpGaD
Metyrapone—Vomiting—Timolol—glaucoma	0.000373	0.00178	CcSEcCtD
Metyrapone—Headache—Timolol—glaucoma	0.000368	0.00175	CcSEcCtD
Metyrapone—ABCC3—NRF2 pathway—TGFB2—glaucoma	0.000367	0.0059	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000355	0.00571	CbGpPWpGaD
Metyrapone—CYP11B2—Biological oxidations—GSTM1—glaucoma	0.000353	0.00567	CbGpPWpGaD
Metyrapone—Nausea—Timolol—glaucoma	0.000349	0.00166	CcSEcCtD
Metyrapone—CYP11B2—Metapathway biotransformation—GSTM1—glaucoma	0.000348	0.00559	CbGpPWpGaD
Metyrapone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000338	0.00544	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CA5A—glaucoma	0.000334	0.00538	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NARFL—glaucoma	0.000334	0.00538	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000323	0.00519	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—TXN—glaucoma	0.000316	0.00509	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000315	0.00506	CbGpPWpGaD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00031	0.00499	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000309	0.00497	CbGpPWpGaD
Metyrapone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000306	0.00492	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—GSTM1—glaucoma	0.000304	0.00489	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—GSTM1—glaucoma	0.0003	0.00482	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000295	0.00475	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	0.000282	0.00454	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TP53—glaucoma	0.000275	0.00442	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000256	0.00411	CbGpPWpGaD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000255	0.0041	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—GSTM1—glaucoma	0.000249	0.00401	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NARFL—glaucoma	0.000241	0.00387	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CA5A—glaucoma	0.000241	0.00387	CbGpPWpGaD
Metyrapone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00023	0.0037	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—TGFB2—glaucoma	0.00023	0.0037	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—GSTT1—glaucoma	0.000215	0.00346	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000197	0.00317	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CA1—glaucoma	0.000189	0.00305	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CTSA—glaucoma	0.000183	0.00295	CbGpPWpGaD
Metyrapone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000181	0.0029	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CA2—glaucoma	0.000173	0.00279	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	0.000172	0.00277	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP1B1—glaucoma	0.000171	0.00276	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—GSTT1—glaucoma	0.00017	0.00273	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000169	0.00272	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000169	0.00272	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CA1—glaucoma	0.000163	0.00263	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CTSA—glaucoma	0.000158	0.00254	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—GSTM1—glaucoma	0.000156	0.00251	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NARFL—glaucoma	0.000151	0.00243	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CA5A—glaucoma	0.000151	0.00243	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CA2—glaucoma	0.000149	0.0024	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000146	0.00235	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000146	0.00235	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000146	0.00235	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000144	0.00232	CbGpPWpGaD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000144	0.00232	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—GSTM1—glaucoma	0.000137	0.0022	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—CYP1B1—glaucoma	0.000135	0.00218	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	0.000134	0.00215	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—TXN—glaucoma	0.000122	0.00196	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CA5A—glaucoma	0.000119	0.00192	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NARFL—glaucoma	0.000119	0.00192	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000118	0.0019	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CA1—glaucoma	0.000118	0.00189	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CTSA—glaucoma	0.000114	0.00183	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000111	0.00179	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00011	0.00178	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—GSTM1—glaucoma	0.000108	0.00174	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CA2—glaucoma	0.000108	0.00173	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	0.000107	0.00172	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—TXN—glaucoma	0.000105	0.00169	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000105	0.00169	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000105	0.00169	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.6e-05	0.00154	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.51e-05	0.00153	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTT1—glaucoma	9.47e-05	0.00152	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTT1—glaucoma	8.16e-05	0.00131	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.89e-05	0.00127	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.63e-05	0.00123	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TXN—glaucoma	7.58e-05	0.00122	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ABCA1—glaucoma	7.54e-05	0.00121	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP1B1—glaucoma	7.54e-05	0.00121	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CA1—glaucoma	7.36e-05	0.00118	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CTSA—glaucoma	7.13e-05	0.00115	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.91e-05	0.00111	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.85e-05	0.0011	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CA2—glaucoma	6.74e-05	0.00108	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.58e-05	0.00106	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCA1—glaucoma	6.5e-05	0.00105	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP1B1—glaucoma	6.5e-05	0.00105	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.29e-05	0.00101	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.2e-05	0.000997	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTM1—glaucoma	6.03e-05	0.00097	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTT1—glaucoma	5.87e-05	0.000945	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CA1—glaucoma	5.82e-05	0.000936	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CTSA—glaucoma	5.64e-05	0.000907	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NARFL—glaucoma	5.53e-05	0.000889	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA5A—glaucoma	5.53e-05	0.000889	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MTHFR—glaucoma	5.33e-05	0.000857	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CA2—glaucoma	5.32e-05	0.000856	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTM1—glaucoma	5.2e-05	0.000836	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.02e-05	0.000808	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOE—glaucoma	4.96e-05	0.000798	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.96e-05	0.000797	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CAV1—glaucoma	4.92e-05	0.000791	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TXN—glaucoma	4.75e-05	0.000763	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.74e-05	0.000762	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP1B1—glaucoma	4.68e-05	0.000753	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCA1—glaucoma	4.68e-05	0.000753	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—glaucoma	4.59e-05	0.000739	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOE—glaucoma	4.28e-05	0.000688	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CAV1—glaucoma	4.24e-05	0.000681	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TXN—glaucoma	3.75e-05	0.000603	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—glaucoma	3.74e-05	0.000602	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NOS3—glaucoma	3.72e-05	0.000598	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTT1—glaucoma	3.68e-05	0.000592	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—glaucoma	3.4e-05	0.000547	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—glaucoma	3.31e-05	0.000532	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NOS3—glaucoma	3.2e-05	0.000515	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOE—glaucoma	3.08e-05	0.000495	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAV1—glaucoma	3.05e-05	0.000491	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCA1—glaucoma	2.93e-05	0.000472	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP1B1—glaucoma	2.93e-05	0.000472	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—glaucoma	2.93e-05	0.000471	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTT1—glaucoma	2.91e-05	0.000468	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA1—glaucoma	2.7e-05	0.000434	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CTSA—glaucoma	2.61e-05	0.000421	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA2—glaucoma	2.47e-05	0.000397	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—glaucoma	2.34e-05	0.000377	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP1B1—glaucoma	2.32e-05	0.000373	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCA1—glaucoma	2.32e-05	0.000373	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NOS3—glaucoma	2.31e-05	0.000371	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—glaucoma	2.11e-05	0.000339	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—glaucoma	2.07e-05	0.000333	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOE—glaucoma	1.93e-05	0.00031	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAV1—glaucoma	1.91e-05	0.000307	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—glaucoma	1.85e-05	0.000298	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TXN—glaucoma	1.74e-05	0.00028	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—glaucoma	1.64e-05	0.000263	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOE—glaucoma	1.52e-05	0.000245	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAV1—glaucoma	1.51e-05	0.000243	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NOS3—glaucoma	1.44e-05	0.000232	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTT1—glaucoma	1.35e-05	0.000217	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—glaucoma	1.32e-05	0.000213	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NOS3—glaucoma	1.14e-05	0.000184	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCA1—glaucoma	1.07e-05	0.000173	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP1B1—glaucoma	1.07e-05	0.000173	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—glaucoma	1.04e-05	0.000168	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—glaucoma	8.59e-06	0.000138	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—glaucoma	7.59e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOE—glaucoma	7.07e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAV1—glaucoma	7e-06	0.000113	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NOS3—glaucoma	5.3e-06	8.52e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—glaucoma	4.84e-06	7.79e-05	CbGpPWpGaD
